Bibliography

 

1. Saliba MJ Jr. Heparin in the treatment of burns: a review. BURNS, J International

Society for Burn Injuries. 2001;27:349-358.

2.Reyes A, Astiazaran JA, Chavez CC, Jaramillo F and Saliba MJ. Burns treated with and

without heparin: controlled use in a thermal disaster. Annals of Burns and Fire Disasters.

2001;14(4):183-191.

3. Glucosaminoglycans In Burns: Multi-Center Update: Proceedings: 10th CONGRESS OF

INTERNATIONAL SOCIETY FOR BURN INJURIES, Jerusalem, Israel, Nov 1-5, 1998:

Abstracts of presentations: Saliba, MJ Jr., La Jolla, CA USA. p 10,11,20,34,70; Mangus DJ.

Chico, CA USA. p 20; Ramakrishnan KM., Madras, INDIA. p 11,11, 21; Traber DL.,

Galveston, TX, USA p 11,34; Dmitreinko, O., St. Petersburg, RUSSIA p 11; Hruba, J.

Prague, Czech Republic p 10. Hansbrough JF. San Diego, CA USA p 10.

4. In Proceedings: THE EFFECTS OF HEPARIN IN THE TREATMENT OF BURNS:

INTERNATIONAL MEETING. Feb 24-27 1994. San Diego, CA, USA. Editor: Dr Saliba. Saliba

MJ Jr, p3-8,15-68; Green BE, p9-14; Ramakrishnan KM, p69-73,84-93,123-126; Cox CS,

p74-82; Hansbrough JF, Abst p28; Traber L, p94-122; Mangus DJ, p127+19p; Konigova

R, and Hubra J, p128-131. Reprints: Tel/Fax:USA + 858 454 2686 or write: Michael J.

Saliba Jr., MD. 5582 Thunderbird Lane, La Jolla, CA 92037 USA

5. Rigdon RH, and Wilson H. Capillary permeability and inflammation in rabbits given

heparin. Arch Surg. 1941;43:64-73.

6. Aldrich EM. Studies in burns II. Observations on a vasoconstrictor substance in lymph

from a burned area. Surgery. 1944;15:908-912.

7. Aldrich EM. The effect of heparin on the circulating blood plasma and proteins in

experimental burns. Surgery. 1949;25:686-.

8. McCleary RS, Schaffarzick WH, and Light RH. An experimental study of the effect of

heparin on local pathology of burns Surgery. 1949;26:548-564.

9. Parsons R. Jr, Aldrich EM, and Lehman RP. Studies on burns: effect of heparin and

gravity on tissue loss resulting from third degree burns. Surg Gyn Obstet. 1950;90:722-.

10. Elrod PD, McCleary RS, and Ball OT. An experimental study of the effect of heparin on

survival time following lethal burns. Surg Gyn Obstet. 1951;92:35-42.

11. Green BE, and Artz CP. An appraisal of heparin in burns: Experimental study. Surgical

Forum. 1959;10:343-. And Reference 2:pp9-14.

http://www.salibaburnsinstitute.org/ScienceofHeparin/Bibliographycontent.html (1 of 5)2/8/2010 9:58:52 AM

Bibliography

12. Brooks F, Dragstedt LR, Warner L, and Knisely MH. Sludged blood following severe

themal burns. Arch Surg. 1950;61:387-418.

13. Branemark P, Breine V, Joshi M, Urbaschek B. Microvascular pathophysiology of

burned tissue. Ann NY Acad Sci. 1964;150:474-.

14. Keller R. Zor bindung von histamin und serotonin in den mastzellen. Arzneimittel-

Forsch. 1958;8:390-

15. Majno WW, and Palade GE. Studies on inflammation: 1. The effect of histamine and

serotonin on vascular permeability. J Biophys & Biochem Cytol. 1961;11:571-605.

16. Kobayasch Y. Histamin binding by heparin. Biochem & Biophy. 1962;96:20-27.

17. Dolowitz DA, and Dougherty TF. The use of heparin as an antiinflammatory agent.

Laryngoscope. 1960;70:873-.

18. Doughtery TF, and Dolowitz DA. Physiologic actions of heparin not related to blood

clotting. Am J Cardiology. 1964;14:18-.

19. Boyle JP, Smart RH, and Shirley JK. Heparin in treatment of chronic obstructive

bronchopulmonary disease. Am J Cardiology. 1964;14:25-.

20. Ley K, Cerrito M, Arfors KE. Sulfated polysaccharides inhibit leukocyte rolling in rabbit

mesentery venules. Am J Physiol. 1991;260;H1667-H1673.

21. Saliba MJ Jr. Heparin in the treatment of burns. JAMA. 1967;200:650.

22. Saliba MJ Jr. Heparin efficacy in burns. II. Human thermal burn treatment with large

doses of topical and parenteral heparin. Aerospace Medicine. 1970;41:1302-1312.

23. Saliba MJ Jr, Dempsey WC, and Kruggel JL. Large burns in humans, treatment with

heparin. JAMA. 1973;225:261-269.

24. Saliba MJ Jr. Heparin, nature's own burn remedy? Emergency Medicine.

1973;106:111-.

25. Saliba MJ Jr and Saliba RJ. Heparin in burns: dose related and dose dependent effects.

Thrombos Diasthes Haemorrh (Stuttig). 1974;33:113-.

26. Saliba MJ Jr: The effects and uses of heparin in the care of burns that improves

treatment and enhances the quality of life. Acta Chirurgiae Plasticae 1997;39:13-16.

27. Saliba MJ Jr, Covell JM, Bloor CM. Effects of heparin in large doses on the extent of

http://www.salibaburnsinstitute.org/ScienceofHeparin/Bibliographycontent.html (2 of 5)2/8/2010 9:58:52 AM

Bibliography

myocardial ischemia after acute coronary occlusion in the dog. Am J Cardiol. 1976;37:599-

604.

28. Saliba, MJ Jr, Kuzman WJ, and Miller M. Effect of heparin in anticoagulant doses on the

ECG and cardiac enzymes in patients with acute myocardial infarction. Am J Cardiol.

1976;37:604-607.

29. Saliba MJ Jr, and Griner L.A: Heparin efficacy in burns. I. Significant early modification

of experimental third-degree guinea pig thermal burn. Aerospace Med. 1970;41:179-.

30. Chemical mediators of inflammation. In: Cotran RS, Robbins SL, and Kumar V, eds

Robbins Pathologic Basis of Disease 5th Ed. Philadelphia, PA Hardcourt Brace;1994:65.

31. Carr J: The anti-inflammatory action of heparin: heparin as an antagonist to

histamine, bradykinin, and prostaglandin E1. Thromb Res. 1979;16:507-516.

32. Gregrius FK, Rand RW: Scanning electron microscopy of the rat common carotid

artery: III. Heparin effects on platelets. Surgery. 1976;79:584-589.

33. Shanberge JN, Kambayashi J, Nakagawa M. The interaction of platelets with a tritiumlabeled

heparin. Thrombos Res. 1976;9:595-609.

34. Rent R, Nyirman RRR, Fiedel BA, Gewutz H. Potentiation of C1 esterase inhibitor

activity by heparin. Clin Exp Immunol. 1976;23:264-271.

35. Hiebert LM, Lui JM. Heparin protects cultured arterial endothelial cells from damage by

toxic oxygen metabolites. Arteriosclerosis. 1990;83:37-51.

36. Lantz M, Thysell H, Nilsson E, Olsson I. On the binding of tumor-necrosis-factor (TNF)

to heparin and the release in vivo of the TNF-binding protein I by heparin. J Clin Invest.

1991;88:2026-2031.

37. Lider O, Bahav E, Mekori YA, et al. Suppression of experimental autoimmune diseases

and prolongation of allograft survival by treating animals with low doses of heparin. J Clin

Invest. 1989;83:752-766.

38. Robinson DS, Harris PM. The production of lipolytic activity in the circulation of the

hind limb in response to heparin. Q J Exp Physiol. 1955;44:80-90.

39. Griffin MP, Gore DC, Zwischenberger JB, et al. Does heparin improve survival in

experimental porcine gram-negative shock. Circ Shock. 1990;31:343-349.

40. Wright JG, Massop DW, Furst JG, Durham JR, Smead WL. Pre-ischemic heparinization

decreases rat skeletal muscle reperfusion injury. J Cardiovasc Surg 32(sp):II.Ab

41. Sternberg, WC III, Makhoul RG, and Adelman B. Heparin prevents postischemic

endothelial cell dysfunction by a mechanism independent of its anticoagulant activity. J

http://www.salibaburnsinstitute.org/ScienceofHeparin/Bibliographycontent.html (3 of 5)2/8/2010 9:58:52 AM

Bibliography

Vasc Surg. 1993;17:318-327.

42. Travis MJ MD, Taira M, Jaques, Bartlett RH MD. Heparin in experimental full-thickness

burns: a comparative study. Proceedings Am Burn Assoc 1978 p10:(ab48

43. Mangus DJ, Falces E, Gilchrist DR. Heparinization and the use of culture-specific

antibiotic liquids in the treatment of large burns. In Proceedings: Ref 2;p127+19pSuppl.

44. Ramakrishnan KM, and Jayaraman V. Clinical uses of heparin in burns in Madras,

India. In: Proceedings EFFECTS OF HEPARIN IN BURNS. INTERNATIONAL MEETING. San

Diego, CA USA 1994;p 69-73. Dr Saliba, Editor Tel/Fax+ 858 454 2686.

45. Ramarkrishnan KM, and Jayaraman V. Heparin effects in burn pathophysiology. In:

Proceedings. See Ref 46. 1994;p123-126. Dr Saliba, Editor Tel/Fax: 858 454 2686

46. Ramakrishnan KM, and Jayaraman V. Beneficial effects of topical heparin in burn

wound healing. In: Proceedings. Ref 2. 1994;p84-93. And Ref 1. 1998;p11.

47. Ramakrishnan KM: Burn reduction in burn facial oedema, burn extension, and grafts in

burned humans using heparin administered parenterally. In Proceedings. Ref 2 1994;p87-

93 and Ref 1 1998:p11.

48. Ramakrishnan KM, Babu M. and Ramachandran K. Effects of heparin on collagen in

burns. The International Transaction of the Plastic and Reconstructive Surgery Congress.

Montreal Canada. 1984.

49. Ramakrishnan KM, Babu M, and Ramachandran K. Altered pattern of collagen

synthesis in burns treated with both systemic and local heparin use that improved burn

care. In Proceedings. Ref 2 1994;p124-129. And Ref 1 1998;p21. Contact: K. Mathangi

Ramakrishnan, MB. FRCS. M.Ch. D.Sc., Director, Pediatric Burn ICU & Plastic Surg Chief,

Childs Trust Hospital, Madras India. Fax: + 91 44 823 4044.

50. Dmitrienko O., Bagnenko S., Kuzulin D., Ankin Tu., Takimov D. Experiences with

heparin care in burned patients: with topical and parenteral use. St Petersburg Russia.

10th ISBI (See Ref 1.) 1998:p11. Contact: Dr Dmitrienko Tel/Fax: + 7 812 314 2233.

51. Saliba MJ, Bonilla A, and Zayas C. Initial heparin use topically and parenterally in

burned children in El Salvador. 1999: Preprint.

52. Bonilla A, Saravia M, Zayas C, and Saliba M. Heparin effects by parenteral, topical,

and inhalation in human burns in El Salvador. 1999: Preprint.

53. Azizkhlan, et. al. Mast cell heparin stimulates migration of capillary endothelial cells in

vitro. J Exp Med. 1980;152:931-.

54. Macaig T et al. Heparin binds endothelial cell growth factor, the principal endothelial

cell mitogen in bovine brain. Science. 1984;225:932-.

http://www.salibaburnsinstitute.org/ScienceofHeparin/Bibliographycontent.html (4 of 5)2/8/2010 9:58:52 AM

Bibliography

55. Folkman J. Weisz PB, Joullie MM, Li WW, Ewing WR. Control of angiogenesis with

synthetic heparin substitutes. Science 1989;243:1490-1493.

56. Zapata-Sirvant RL, Hansbrough JF, Greenleaf GE, et al. Reduction of bacterial

translocation and intestinal structure alterations by heparin in a murine burn injury model.

The Journal of Trauma. 1994;36:1-6. And in Ref 1 and 2 of this review.

57. Gianotti L, Alexander JW, Fukushima R, Pyles T. Reduction of bacterial translocation

with oral fibroblast growth factor and sucralfate. Am J Surg. 1993;165:195-200.

58. Hruba J. Prevention of stress bleeding in burn medicine. Using heparin and sucralfate.

In Proceedings Ref 2. 1994:p127-131. And in Ref 1.

59. Ferrao AV and Mason RM: The effect of heparin on cell proliferation and type-I

collagen synthesis by adult human dermal fibroblasts. Biochemica et Biophysica Acta

1993;1180:225-230.

60. McCarthy DW; Downing MT; Brigstock DR; Luquette MH; Brown KD; Abad MS; Gesner

GE. Production of heparin-binding epidermal growth factor-like growth factor at sites of

thermal injury in pediatric patients. J Investigative Dermatology. 106:49-56.

61. Ehrlich H.Rr; Griswold TR; Rajaratanam JBM: Studies on vascular smooth muscle cells

and dermal fibroblast in collagen matrices. effects of heparin. Exp Cell Res, 1986;164:154-

162.

62. Cox CS, Zwischenberger JB, Traber DL, et al. Heparin improves oxygenation and

minimizes barotrauma after severe smoke inhalation in ovine model. Surg Gynecol Obstet.

1993;76:339-349.

63. Brown M, Desai M, Traber L.D., et al. Dimethylsulfoxide with heparin in treatment of

smoke inhalation injury. J Burn Care Rehabil. 9:22-25. And Circ Shock 1988;9:22-25.

64. Desai MH MD, Mlcak RRT RCP, Richardson RCP RRT, et al. Reduction in mortality in

pediatric patients with inhalation injury with aerosolized heparin/acetylcystine therapy. J

Burn Care Rehabil. 1998;19:(3)210-13.